Childress Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Childress Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-148	Closed	-$11K	–	1099
2020 Q4	$11K	Buy	+148	New	+$7.75K	0.01%	537

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Childress Capital Advisors's BEAT Position: Q1 2021 in Review

Childress Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 148 shares — an estimated $11K sold.

Childress Capital Advisors first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Childress Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Childress Capital Advisors sold 148 BioTelemetry, Inc. shares in Q1 2021, an estimated $11K.
Childress Capital Advisors first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Childress Capital Advisors's BioTelemetry, Inc. position peaked at $11K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.